S1PR1 and B-cell chronic lymphocytic leukemia: In keeping with the inability of ibrutinib or fostamatinib to upregulate S1PR1, preincubation of CLL cells with either of these drugs did not enhance migration toward S1P (Supplemental Fig. 3A).